Innovation is the heart of progress, and Neurovalens is leading the charge. At this year’s Life Science Industry Awards, we were thrilled and honoured to have our efforts recognized by winning Innovation of the Year 2025. Held in Dublin, this prestigious event celebrates the trailblazers shaping Ireland’s life sciences sector, and we are proud to be part of this incredible community.
Just last year, the company was celebrated as the Small Life Sciences Company of the Year, underlining our consistent impact and commitment to advancing health-tech solutions.
This recognition fuels Neurovalens’ relentless passion for innovation and pushing boundaries. Each award speaks to the dedication and innovation that our team pours into solving some of the world’s most pressing health challenges.
Our work focuses on noninvasive neurostimulation technology designed to improve key health aspects such as sleep and anxiety. This ability to influence the deep areas of the brain, the hypothalamus and the brain stem without surgery or medication sets our products apart and showcases how technology and health can intersect to truly make lives better.
Winning Innovation of the Year is proof that bold ideas and relentless commitment can achieve great things. It motivates us to push the boundaries of what is possible in the life sciences industry.
We’d like to extend our gratitude to the organizers of the Life Science Industry Awards for shining a spotlight on the progress and innovation occurring within our community. This honor fuels us to continue striving for breakthroughs that not only win awards but also transform lives.
To our team, supporters, and collaborators across the globe, thank you for being part of this exciting journey. The best is yet to come.
Keep up to date with our latest products, research and company news.
Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world’s greatest health challenges.
Our medical device technology offers unparalleled transdermal activation of the homeostatic nuclei of the brainstem and hypothalamus, allowing for alterations in autonomic function, circadian regulation and Neuro-metabolic influence.